Standard BioTools (LAB) Revenue & Revenue Breakdown

Overview ForecastOwnership Financials Chart Transcripts

Standard BioTools Revenue Highlights

Latest Revenue (Y)

$106.34M

Latest Revenue (Q)

$44.97M

Main Segment (Y)

Product And Service

Main Geography (Y)

Americas

Standard BioTools Revenue by Period

Standard BioTools Revenue by Year

Date	Revenue	Change
2023-12-31	$106.34M	8.57%
2022-12-31	$97.95M	-24.99%
2021-12-31	$130.58M	-5.47%
2020-12-31	$138.14M	17.83%
2019-12-31	$117.24M	3.79%
2018-12-31	$112.96M	10.82%
2017-12-31	$101.94M	-2.40%
2016-12-31	$104.45M	-8.95%
2015-12-31	$114.71M	-1.50%
2014-12-31	$116.46M	63.60%
2013-12-31	$71.18M	36.02%
2012-12-31	$52.33M	22.09%
2011-12-31	$42.87M	27.73%
2010-12-31	$33.56M	32.06%
2009-12-31	$25.41M	65.58%
2008-12-31	$15.35M	110.96%
2007-12-31	$7.28M	13.71%
2006-12-31	$6.40M	-95.10%
2001-12-31	$130.58M	-

Standard BioTools generated $106.34M in revenue during NA 2023, up 8.57% compared to the previous quarter, and up 94.14% compared to the same period a year ago.

Standard BioTools Revenue by Quarter

Date	Revenue	Change
2024-09-30	$44.97M	20.87%
2024-06-30	$37.20M	-18.30%
2024-03-31	$45.54M	61.56%
2023-12-31	$28.19M	11.12%
2023-09-30	$25.37M	-8.31%
2023-06-30	$27.67M	10.14%
2023-03-31	$25.12M	-7.04%
2022-12-31	$27.02M	5.36%
2022-09-30	$25.65M	36.58%
2022-06-30	$18.78M	-29.15%
2022-03-31	$26.50M	-30.74%
2021-12-31	$38.27M	34.24%
2021-09-30	$28.50M	-8.10%
2021-06-30	$31.02M	-5.42%
2021-03-31	$32.79M	-26.48%
2020-12-31	$44.61M	11.91%
2020-09-30	$39.86M	52.97%
2020-06-30	$26.06M	-5.65%
2020-03-31	$27.62M	-14.87%
2019-12-31	$32.44M	22.43%
2019-09-30	$26.50M	-6.03%
2019-06-30	$28.20M	-6.36%
2019-03-31	$30.11M	-6.85%
2018-12-31	$32.33M	11.61%
2018-09-30	$28.96M	9.59%
2018-06-30	$26.43M	4.67%
2018-03-31	$25.25M	-9.00%
2017-12-31	$27.75M	12.11%
2017-09-30	$24.75M	3.49%
2017-06-30	$23.91M	-6.35%
2017-03-31	$25.53M	1.79%
2016-12-31	$25.08M	13.04%
2016-09-30	$22.19M	-21.22%
2016-06-30	$28.17M	-2.88%
2016-03-31	$29.00M	-5.60%
2015-12-31	$30.72M	7.26%
2015-09-30	$28.64M	0.09%
2015-06-30	$28.62M	7.07%
2015-03-31	$26.73M	-20.19%
2014-12-31	$33.49M	13.01%
2014-09-30	$29.64M	7.35%
2014-06-30	$27.61M	7.32%
2014-03-31	$25.72M	23.19%
2013-12-31	$20.88M	14.18%
2013-09-30	$18.29M	4.62%
2013-06-30	$17.48M	20.26%
2013-03-31	$14.54M	-7.18%
2012-12-31	$15.66M	22.51%
2012-09-30	$12.78M	-1.28%
2012-06-30	$12.95M	18.30%
2012-03-31	$10.95M	-15.78%
2011-12-31	$13.00M	22.65%
2011-09-30	$10.60M	0.19%
2011-06-30	$10.58M	21.61%
2011-03-31	$8.70M	-16.01%
2010-12-31	$10.36M	22.31%
2010-09-30	$8.47M	5.52%
2010-06-30	$8.02M	19.46%
2010-03-31	$6.72M	-11.90%
2009-12-31	$7.62M	-

Standard BioTools generated $44.97M in revenue during Q3 2024, up 20.87% compared to the previous quarter, and up 162.54% compared to the same period a year ago.

Standard BioTools Revenue Breakdown

Standard BioTools Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Product	$79.20M	$72.45M	$100.38M	$99.94M	$95.42M
Service	$25.98M	$23.71M	$25.92M	$22.58M	$21.28M
Consumables	$41.74M	$46.79M	$57.88M	$45.41M	-
Instruments	$37.46M	$25.66M	$42.50M	$50.00M	-
Product And Service	$105.18M	$96.17M	-	-	-
Product and Service, Other	$1.16M	$964.00K	$1.73M	$6.76M	-
Collaboration Revenue	-	$818.00K	$2.56M	-	-
License	-	$964.00K	$147.00K	-	-
Grant	-	-	$1.58M	-	-
Grant Revenue	-	-	-	-	$550.00K

Standard BioTools's latest annual revenue breakdown by segment (product or service), as of Dec 23: Product And Service (36.18%), Product (27.24%), Consumables (14.36%), Instruments (12.89%), Service (8.94%), and Product and Service, Other (0.40%).

Quarterly Revenue by Product

Product/Service	Sep 24	Mar 24	Dec 23	Sep 23	Jun 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19	Jun 19
Collaboration and Other Revenue	$938.00K	$921.00K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Service	$24.44M	$21.03M	$13.59M	$6.57M	$5.82M	$5.91M	$5.86M	$5.81M	$6.14M	$6.99M	$6.02M	$6.63M	$6.29M	$6.12M	$6.13M	$5.14M	$5.19M	$5.40M	$5.63M	$4.96M
Product	$19.59M	$23.59M	$38.82M	$18.71M	$21.66M	$20.92M	$19.31M	$12.22M	$20.00M	$31.08M	$21.94M	$22.63M	$24.73M	$34.35M	$29.21M	$17.41M	$18.98M	$26.69M	$20.67M	$23.23M
Product And Service	$44.03M	$44.62M	$52.41M	$25.28M	$27.49M	$26.82M	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Instruments	$5.59M	$4.90M	$16.87M	$9.00M	$11.59M	$2.66M	$7.52M	$14.55M	$10.06M	$10.18M	$7.71M	$12.62M	$8.58M	$9.47M	$15.80M	$9.16M	$12.20M	-	-	-
Consumables	$14.01M	$10.41M	$21.95M	$9.71M	$10.08M	$9.56M	$12.48M	$16.53M	$11.88M	$12.45M	$17.02M	$16.59M	$8.83M	$9.51M	$10.88M	$11.51M	$11.03M	-	-	-
Product and Service, Other	-	-	$892.00K	$90.00K	$180.00K	$-621.00K	$396.00K	$268.00K	$54.00K	$461.00K	$914.00K	$300.00K	$1.45M	$1.34M	$513.00K	-	-	-	-	-
Grant	-	-	-	-	-	-	-	-	-	-	$461.00K	$821.00K	$300.00K	$1.34M	$450.00K	-	-	-	-	-
License	-	-	-	-	-	-	-	$396.00K	$268.00K	$54.00K	-	$93.00K	-	-	$63.00K	-	-	-	-	-
Collaboration Revenue	-	-	-	-	-	-	-	$356.00K	$88.00K	$139.00K	$90.00K	$1.48M	$2.69M	$3.18M	$3.00M	-	-	-	-	-
Grant Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$350.00K	$350.00K	$200.00K	-

Standard BioTools's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: Product And Service (40.55%), Service (22.50%), Product (18.04%), Consumables (12.90%), Instruments (5.14%), and Collaboration and Other Revenue (0.86%).

Standard BioTools Revenue Breakdown by Country

Annual Revenue by Country

Country	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
EMEA	$36.20M	$33.14M	$42.72M	$37.78M	$40.02M
Asia Pacific	$23.94M	$20.83M	$23.98M	$25.78M	$30.20M
Americas	$46.20M	$43.98M	$63.88M	$74.59M	$47.02M

Standard BioTools's latest annual revenue breakdown by geography, as of Dec 23: Americas (43.44%), EMEA (34.04%), and Asia Pacific (22.52%).

Quarterly Revenue by Country

Country	Sep 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
Asia Pacific	$5.16M	$8.36M	$6.20M	$6.34M	$5.78M	$5.62M	$5.74M	$6.45M	$3.67M	$4.96M	$7.79M	$5.38M	$5.68M	$5.13M	$8.17M	$7.37M	$5.56M	$4.68M	$9.07M	$6.29M
Americas	$23.75M	$24.66M	$13.22M	$10.87M	$10.45M	$11.66M	$10.50M	$11.12M	$9.43M	$12.93M	$16.22M	$13.01M	$16.12M	$18.52M	$22.15M	$23.65M	$13.94M	$14.84M	$11.81M	$11.11M
EMEA	$16.06M	$12.52M	$8.77M	$8.16M	$11.44M	$7.84M	$10.78M	$8.07M	$5.67M	$8.61M	$14.25M	$10.11M	$9.22M	$9.14M	$14.29M	$8.84M	$6.56M	$8.10M	-	-
Europe	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$9.09M

Standard BioTools's latest quarterly revenue breakdown by geography, as of Sep 24: Americas (52.82%), EMEA (35.71%), and Asia Pacific (11.48%).

Standard BioTools Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
FONR	FONAR	$102.88B	$25.94M
BNR	Burning Rock Biotech	$537.43M	$125.62M
NOTV	Inotiv	$490.74M	$105.79M
LAB	Standard BioTools	$106.34M	$44.97M
STIM	Neuronetics	$71.35M	$16.45M
MDXH	MDxHealth SA	$70.19M	$19.83M
BDSX	Biodesix	$49.09M	$18.15M
DRIO	DarioHealth	$20.35M	$6.25M
SERA	Sera Prognostics	$306.00K	$24.00K
NDRA	ENDRA Life Sciences	-	-

LAB Revenue FAQ

What is Standard BioTools’s yearly revenue?

Standard BioTools's yearly revenue for 2023 was $106.34M, representing an increase of 8.57% compared to 2022. The company's yearly revenue for 2022 was $97.95M, representing a decrease of -24.99% compared to 2021. LAB's yearly revenue for 2021 was $130.58M, representing a decrease of -5.47% compared to 2020.

What is Standard BioTools’s quarterly revenue?

Standard BioTools's quarterly revenue for Q3 2024 was $44.97M, a 20.87% increase from the previous quarter (Q2 2024), and a 77.27% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $37.2M, a -18.30% decrease from the previous quarter (Q1 2024), and a 34.48% increase year-over-year (Q2 2023). LAB's quarterly revenue for Q1 2024 was $45.54M, a 61.56% increase from the previous quarter (Q4 2023), and a 81.30% increase year-over-year (Q1 2023).

What is Standard BioTools’s revenue growth rate?

Standard BioTools's revenue growth rate for the last 3 years (2021-2023) was -18.56%, and for the last 5 years (2019-2023) was -9.30%.

What are Standard BioTools’s revenue streams?

Standard BioTools's revenue streams in c 23 are Product, Service, Consumables, Instruments, Product And Service, and Product and Service, Other. Product generated $79.2M in revenue, accounting 27.24% of the company's total revenue, up 9.31% year-over-year. Service generated $25.98M in revenue, accounting 8.94% of the company's total revenue, up 9.56% year-over-year. Consumables generated $41.74M in revenue, accounting 14.36% of the company's total revenue, down -10.80% year-over-year. Instruments generated $37.46M in revenue, accounting 12.89% of the company's total revenue, up 45.96% year-over-year. Product And Service generated $105.18M in revenue, accounting 36.18% of the company's total revenue, up 9.37% year-over-year. Product and Service, Other generated $1.16M in revenue, accounting 0.40% of the company's total revenue, up 20.54% year-over-year.

What is Standard BioTools’s main source of revenue?

For the fiscal year ending Dec 23, the largest source of revenue of Standard BioTools was Product And Service. This segment made a revenue of $105.18M, representing 36.18% of the company's total revenue.